Global Retirement Partners’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-44
Closed -$1.11K 3516
2024
Q2
$1.11K Hold
44
﹤0.01% 3135
2024
Q1
$1.28K Sell
44
-200
-82% -$5.48K ﹤0.01% 2901
2023
Q4
$6.01K Hold
244
﹤0.01% 2250
2023
Q3
$4.57K Sell
244
-6
-2% -$133 ﹤0.01% 2223
2023
Q2
$5.99K Buy
250
+17
+7% +$409 ﹤0.01% 2133
2023
Q1
$5.6K Sell
233
-155
-40% -$3.9K ﹤0.01% 2125
2022
Q4
$9.7K Hold
388
﹤0.01% 1794
2022
Q3
$10K Sell
388
-20
-5% -$510 ﹤0.01% 1674
2022
Q2
$9K Hold
408
﹤0.01% 1669
2022
Q1
$8K Buy
+408
New +$12.1K ﹤0.01% 1692
2021
Q4
Sell
-408
Closed -$19K 374
2021
Q3
$19K Hold
408
﹤0.01% 1211
2021
Q2
$20K Hold
408
﹤0.01% 1182
2021
Q1
$21K Sell
408
-6
-1% -$328 ﹤0.01% 1088
2020
Q4
$21K Buy
414
+5
+1% +$225 ﹤0.01% 1010
2020
Q3
$16K Buy
409
+122
+43% +$4.97K ﹤0.01% 989
2020
Q2
$12K Buy
+287
New +$11K ﹤0.01% 1057
2019
Q2
Sell
-180
Closed -$5K 1598
2019
Q1
$5K Hold
180
﹤0.01% 1225
2018
Q4
$4K Hold
180
﹤0.01% 1192
2018
Q3
$6K Sell
180
-170
-49% -$5.74K ﹤0.01% 1163
2018
Q2
$11K Hold
350
﹤0.01% 968
2018
Q1
$11K Buy
+350
New +$11.4K ﹤0.01% 934

Other funds holding BBC

Global Retirement Partners's BBC Position: Q3 2024 in Review

Global Retirement Partners sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q3 2024, closing a stake of 44 shares — an estimated $1.11K sold.

Global Retirement Partners first reported a position in BBC in Q1 2018 and held it in 21 quarters. The position peaked at $21K in Q1 2021. 13 funds tracked by Wall St. Rank hold BBC as of Q3 2024.

  • Global Retirement Partners reported no remaining Virtus Biotech Clinical Trials ETF position as of Q3 2024 after selling out during the quarter.
  • Global Retirement Partners sold 44 Virtus Biotech Clinical Trials ETF shares in Q3 2024, an estimated $1.11K.
  • Global Retirement Partners first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2018 and held it in 21 quarters.
  • Global Retirement Partners's Virtus Biotech Clinical Trials ETF position peaked at $21K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2024.

Based on Global Retirement Partners's 13F filing for Q3 2024, filed 16 Oct 2024.